{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:45:06Z","timestamp":1777963506310,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7568","license":[{"start":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T00:00:00Z","timestamp":1441152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T00:00:00Z","timestamp":1441152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2015,9,10]]},"DOI":"10.1038\/nature15251","type":"journal-article","created":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T09:57:41Z","timestamp":1441187861000},"page":"206-211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":438,"title":["Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth"],"prefix":"10.1038","volume":"525","author":[{"given":"Jiajun","family":"Zhu","sequence":"first","affiliation":[]},{"given":"Morgan A.","family":"Sammons","sequence":"additional","affiliation":[]},{"given":"Greg","family":"Donahue","sequence":"additional","affiliation":[]},{"given":"Zhixun","family":"Dou","sequence":"additional","affiliation":[]},{"given":"Masoud","family":"Vedadi","sequence":"additional","affiliation":[]},{"given":"Matth\u00e4us","family":"Getlik","sequence":"additional","affiliation":[]},{"given":"Dalia","family":"Barsyte-Lovejoy","sequence":"additional","affiliation":[]},{"given":"Rima","family":"Al-awar","sequence":"additional","affiliation":[]},{"given":"Bryson W.","family":"Katona","sequence":"additional","affiliation":[]},{"given":"Ali","family":"Shilatifard","sequence":"additional","affiliation":[]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[]},{"given":"Xianxin","family":"Hua","sequence":"additional","affiliation":[]},{"given":"Cheryl H.","family":"Arrowsmith","sequence":"additional","affiliation":[]},{"given":"Shelley L.","family":"Berger","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,9,2]]},"reference":[{"key":"BFnature15251_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature12912","volume":"505","author":"MS Lawrence","year":"2014","unstructured":"Lawrence, M. S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495\u2013501 (2014)","journal-title":"Nature"},{"key":"BFnature15251_CR2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2004.11.006","volume":"119","author":"GA Lang","year":"2004","unstructured":"Lang, G. A. et al. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 119, 861\u2013872 (2004)","journal-title":"Cell"},{"key":"BFnature15251_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2004.11.004","volume":"119","author":"KP Olive","year":"2004","unstructured":"Olive, K. P. et al. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 119, 847\u2013860 (2004)","journal-title":"Cell"},{"key":"BFnature15251_CR4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.cell.2011.12.017","volume":"148","author":"WA Freed-Pastor","year":"2012","unstructured":"Freed-Pastor, W. A. et al. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell 148, 244\u2013258 (2012)","journal-title":"Cell"},{"key":"BFnature15251_CR5","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1038\/ncomms3935","volume":"4","author":"C Zhang","year":"2013","unstructured":"Zhang, C. et al. Tumour-associated mutant p53 drives the Warburg effect. Nat. Commun. 4, 2935 (2013)","journal-title":"Nat. Commun."},{"key":"BFnature15251_CR6","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/onc.2014.46","volume":"34","author":"M Subramanian","year":"2015","unstructured":"Subramanian, M. et al. A mutant p53\/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis. Oncogene 34, 1094\u20131104 (2015)","journal-title":"Oncogene"},{"key":"BFnature15251_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.cell.2014.01.066","volume":"157","author":"S Weissmueller","year":"2014","unstructured":"Weissmueller, S. et al. Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor \u03b2 signaling. Cell 157, 382\u2013394 (2014)","journal-title":"Cell"},{"key":"BFnature15251_CR8","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1101\/gad.181685.111","volume":"26","author":"PM Do","year":"2012","unstructured":"Do, P. M. et al. Mutant p53 cooperates with ETS2 to promote etoposide resistance. Genes Dev. 26, 830\u2013845 (2012)","journal-title":"Genes Dev."},{"key":"BFnature15251_CR9","doi-asserted-by":"publisher","first-page":"7447","DOI":"10.1158\/0008-5472.CAN-04-1568","volume":"64","author":"MJ Scian","year":"2004","unstructured":"Scian, M. J. et al. Modulation of gene expression by tumor-derived p53 mutants. Cancer Res. 64, 7447\u20137454 (2004)","journal-title":"Cancer Res."},{"key":"BFnature15251_CR10","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1038\/oncsis.2013.15","volume":"2","author":"S Garritano","year":"2013","unstructured":"Garritano, S., Inga, A., Gemignani, F. & Landi, S. More targets, more pathways and more clues for mutant p53. Oncogenesis 2, e54 (2013)","journal-title":"Oncogenesis"},{"key":"BFnature15251_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","volume":"150","author":"MA Dawson","year":"2012","unstructured":"Dawson, M. A. & Kouzarides, T. Cancer epigenetics: from mechanism to therapy. Cell 150, 12\u201327 (2012)","journal-title":"Cell"},{"key":"BFnature15251_CR12","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/nm.3336","volume":"19","author":"WL Tam","year":"2013","unstructured":"Tam, W. L. & Weinberg, R. A. The epigenetics of epithelial-mesenchymal plasticity in cancer. Nature Med. 19, 1438\u20131449 (2013)","journal-title":"Nature Med."},{"key":"BFnature15251_CR13","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides, T. Chromatin modifications and their function. Cell 128, 693\u2013705 (2007)","journal-title":"Cell"},{"key":"BFnature15251_CR14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2007.01.015","volume":"128","author":"B Li","year":"2007","unstructured":"Li, B., Carey, M. & Workman, J. L. The role of chromatin during transcription. Cell 128, 707\u2013719 (2007)","journal-title":"Cell"},{"key":"BFnature15251_CR15","doi-asserted-by":"crossref","unstructured":"The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57\u201374 (2012)","DOI":"10.1038\/nature11247"},{"key":"BFnature15251_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.molcel.2013.08.037","volume":"52","author":"J Gertz","year":"2013","unstructured":"Gertz, J. et al. Distinct properties of cell-type-specific and shared transcription factor binding sites. Mol. Cell 52, 25\u201336 (2013)","journal-title":"Mol. Cell"},{"key":"BFnature15251_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev.biochem.79.081507.103945","volume":"80","author":"PC Hollenhorst","year":"2011","unstructured":"Hollenhorst, P. C., McIntosh, L. P. & Graves, B. J. Genomic and biochemical insights into the specificity of ETS transcription factors. Annu. Rev. Biochem. 80, 437\u2013471 (2011)","journal-title":"Annu. Rev. Biochem."},{"key":"BFnature15251_CR18","doi-asserted-by":"publisher","first-page":"11145","DOI":"10.1073\/pnas.1404139111","volume":"111","author":"S Xiong","year":"2014","unstructured":"Xiong, S. et al. Pla2g16 phospholipase mediates gain-of-function activities of mutant p53. Proc. Natl Acad. Sci. USA 111, 11145\u201311150 (2014)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature15251_CR19","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.devcel.2009.10.006","volume":"17","author":"AK Voss","year":"2009","unstructured":"Voss, A. K., Collin, C., Dixon, M. P. & Thomas, T. Moz and retinoic acid coordinately regulate H3K9 acetylation, Hox gene expression, and segment identity. Dev. Cell 17, 674\u2013686 (2009)","journal-title":"Dev. Cell"},{"key":"BFnature15251_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1146\/annurev-biochem-051710-134100","volume":"81","author":"A Shilatifard","year":"2012","unstructured":"Shilatifard, A. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu. Rev. Biochem. 81, 65\u201395 (2012)","journal-title":"Annu. Rev. Biochem."},{"key":"BFnature15251_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.molcel.2013.12.001","volume":"53","author":"F Cao","year":"2014","unstructured":"Cao, F. et al. Targeting MLL1 H3K4 methyltransferase activity in mixed-lineage leukemia. Mol. Cell 53, 247\u2013261 (2014)","journal-title":"Mol. Cell"},{"key":"BFnature15251_CR22","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.1128\/MCB.00924-09","volume":"29","author":"P Wang","year":"2009","unstructured":"Wang, P. et al. Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II. Mol. Cell. Biol. 29, 6074\u20136085 (2009)","journal-title":"Mol. Cell. Biol."},{"key":"BFnature15251_CR23","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S1097-2765(02)00741-4","volume":"10","author":"TA Milne","year":"2002","unstructured":"Milne, T. A. et al. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol. Cell 10, 1107\u20131117 (2002)","journal-title":"Mol. Cell"},{"key":"BFnature15251_CR24","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S1097-2765(02)00740-2","volume":"10","author":"T Nakamura","year":"2002","unstructured":"Nakamura, T. et al. ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol. Cell 10, 1119\u20131128 (2002)","journal-title":"Mol. Cell"},{"key":"BFnature15251_CR25","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/sj.bjc.6605335","volume":"101","author":"LY Lim","year":"2009","unstructured":"Lim, L. Y., Vidnovic, N., Ellisen, L. W. & Leong, C. O. Mutant p53 mediates survival of breast cancer cells. Br. J. Cancer 101, 1606\u20131612 (2009)","journal-title":"Br. J. Cancer"},{"key":"BFnature15251_CR26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature14430","volume":"532","author":"EM Alexandrova","year":"2015","unstructured":"Alexandrova, E. M. et al. Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment. Nature 532, 352\u2013356 (2015)","journal-title":"Nature"},{"key":"BFnature15251_CR27","first-page":"64","volume":"61","author":"Q Zhu","year":"2001","unstructured":"Zhu, Q., Wani, G., Wani, M. A. & Wani, A. A. Human homologue of yeast Rad23 protein A interacts with p300\/cyclic AMP-responsive element binding (CREB)-binding protein to down-regulate transcriptional activity of p53. Cancer Res. 61, 64\u201370 (2001)","journal-title":"Cancer Res."},{"key":"BFnature15251_CR28","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1056\/NEJMra1112635","volume":"367","author":"MA Dawson","year":"2012","unstructured":"Dawson, M. A., Kouzarides, T. & Huntly, B. J. Targeting epigenetic readers in cancer. N. Engl. J. Med. 367, 647\u2013657 (2012)","journal-title":"N. Engl. J. Med."},{"key":"BFnature15251_CR29","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature10806","volume":"482","author":"J Huang","year":"2012","unstructured":"Huang, J. et al. The same pocket in menin binds both MLL and JUND but has opposite effects on transcription. Nature 482, 542\u2013546 (2012)","journal-title":"Nature"},{"key":"BFnature15251_CR30","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1128\/MCB.24.13.5639-5649.2004","volume":"24","author":"A Yokoyama","year":"2004","unstructured":"Yokoyama, A. et al. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol. Cell. Biol. 24, 5639\u20135649 (2004)","journal-title":"Mol. Cell. Biol."},{"key":"BFnature15251_CR31","doi-asserted-by":"publisher","first-page":"7275","DOI":"10.1158\/0008-5472.CAN-06-2369","volume":"67","author":"C Caslini","year":"2007","unstructured":"Caslini, C. et al. Interaction of MLL amino terminal sequences with menin is required for transformation. Cancer Res. 67, 7275\u20137283 (2007)","journal-title":"Cancer Res."},{"key":"BFnature15251_CR32","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/bies.201200007","volume":"34","author":"AT Thiel","year":"2012","unstructured":"Thiel, A. T., Huang, J., Lei, M. & Hua, X. Menin as a hub controlling mixed lineage leukemia. Bioessays 34, 771\u2013780 (2012)","journal-title":"Bioessays"},{"key":"BFnature15251_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cell.2005.09.025","volume":"123","author":"A Yokoyama","year":"2005","unstructured":"Yokoyama, A. et al. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 123, 207\u2013218 (2005)","journal-title":"Cell"},{"key":"BFnature15251_CR34","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nchembio.773","volume":"8","author":"J Grembecka","year":"2012","unstructured":"Grembecka, J. et al. Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia. Nature Chem. Biol. 8, 277\u2013284 (2012)","journal-title":"Nature Chem. Biol."},{"key":"BFnature15251_CR35","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1182\/blood-2012-05-429274","volume":"120","author":"A Shi","year":"2012","unstructured":"Shi, A. et al. Structural insights into inhibition of the bivalent menin\u2013MLL interaction by small molecules in leukemia. Blood 120, 4461\u20134469 (2012)","journal-title":"Blood"},{"key":"BFnature15251_CR36","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1021\/ja306028q","volume":"135","author":"H Karatas","year":"2013","unstructured":"Karatas, H. et al. High-affinity, small-molecule peptidomimetic inhibitors of MLL1\/WDR5 protein\u2013protein interaction. J. Am. Chem. Soc. 135, 669\u2013682 (2013)","journal-title":"J. Am. Chem. Soc."},{"key":"BFnature15251_CR37","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.1021\/jm100139b","volume":"53","author":"H Karatas","year":"2010","unstructured":"Karatas, H., Townsend, E. C., Bernard, D., Dou, Y. & Wang, S. Analysis of the binding of mixed lineage leukemia 1 (MLL1) and histone 3 peptides to WD repeat domain 5 (WDR5) for the design of inhibitors of the MLL1\u2013WDR5 interaction. J. Med. Chem. 53, 5179\u20135185 (2010)","journal-title":"J. Med. Chem."},{"key":"BFnature15251_CR38","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nchembio.1859","volume":"11","author":"F Grebien","year":"2015","unstructured":"Grebien, F. et al. Pharmacological targeting of the Wdr5-MLL interaction in C\/EBP\u03b1 N-terminal leukemia. Nature Chem. Biol. 11, 571\u2013579 (2015)","journal-title":"Nature Chem. Biol."},{"key":"BFnature15251_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1073\/pnas.0909734107","volume":"107","author":"KH Lee","year":"2010","unstructured":"Lee, K. H. et al. A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells. Proc. Natl Acad. Sci. USA 107, 69\u201374 (2010)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature15251_CR40","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1101\/gad.223834.113","volume":"27","author":"PP Shah","year":"2013","unstructured":"Shah, P. P. et al. Lamin B1 depletion in senescent cells triggers large-scale changes in gene expression and the chromatin landscape. Genes Dev. 27, 1787\u20131799 (2013)","journal-title":"Genes Dev."},{"key":"BFnature15251_CR41","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nature Methods 9, 357\u2013359 (2012)","journal-title":"Nature Methods"},{"key":"BFnature15251_CR42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1042\/BJ20121280","volume":"449","author":"G Senisterra","year":"2013","unstructured":"Senisterra, G. et al. Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5. Biochem. J. 449, 151\u2013159 (2013)","journal-title":"Biochem. J."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature15251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature15251","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature15251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:35:01Z","timestamp":1684420501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature15251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,2]]},"references-count":42,"journal-issue":{"issue":"7568","published-print":{"date-parts":[[2015,9,10]]}},"alternative-id":["BFnature15251"],"URL":"https:\/\/doi.org\/10.1038\/nature15251","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725764725.793510645","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,2]]},"assertion":[{"value":"24 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.Z., M.A.S., X.H. and S.L.B. have a related patent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}